A national precision cancer medicine implementation initiative for Norway

Nat Med. 2022 May;28(5):885-887. doi: 10.1038/s41591-022-01777-4.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Neoplasms* / genetics
  • Neoplasms* / therapy
  • Norway
  • Precision Medicine*